2-3 December 2014, Lille, France
BioFIT aims at stimulating and facilitating technology transfer and collaborative projects between academic institutions, pharma/biotech industry, together with other practitioners in the Life Sciences field.
BioFIT is an ideally configured event featuring: • Partnering with qualified and pre-screened one-to-one meetings • Conferences to explore hands-on approaches to tech transfer and Open Innovation • Presenting technologies, licensing opportunities
29-31 October 2014, Buchen/Innsbruck, Austria
Scientific meeting between experts from academia, regulatory authorities and pharmaceutical industry to discuss the latest challenges in oncology drug development. Topics to be covered: Biomarkers for Immunotherapies; Impact on genomic instability for future anti-cancer drug development; Adaptive Licensing; Breakthrough Therapies; Improving oncology drug development for children and adolescents; Cross over in registration studies; Progression-free survival.
18-21 October 2014, Berlin
The ECNP Congress is Europe's largest meeting on applied and translational neuroscience. Annually, it brings together between 4,000 and 7,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain. Spanning the spectrum of human mood, behaviour, cognition and emotion - from basic research to clinical care - the ECNP Congress is Europe's premier showcase for new research, treatments and technologies in applied brain science.
5-8 October 2014, Davos, Switzerland
The 3rd GRF One Health Summit will further develop and strengthen the One Health paradigm and its global movement. In particular this 3rd global gathering will focus on the added value of a global One Health approach and a stronger involvement of the private sector and policy.
The deadline for abstract submission is extended to 30 April 2014. Submit your abstract now on one of the conference topics.
1-3 October 2014, Madrid
ICAR2014 will be a forum to communicate current research priorities and progress, and to identify new approaches and research opportunities in antimicrobial research.